Caricamento...
Intra-Ommaya Compartmental Radioimmunotherapy using (131)I-Omburtamab— Pharmacokinetic Modeling to Optimize Therapeutic Index
PURPOSE: Radioimmunotherapy (RIT) delivered through the cerebrospinal fluid (CSF) has been shown to be a safe and promising treatment for leptomeningeal metastases. Pharmacokinetic models for intra-Ommaya anti-GD2 monoclonal antibody (131)I-3F8 have been proposed to improve therapeutic effect while...
Salvato in:
| Pubblicato in: | Eur J Nucl Med Mol Imaging |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8279045/ https://ncbi.nlm.nih.gov/pubmed/33047248 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-020-05050-z |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|